ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer

ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer

Abstract Background Colon cancer (CC) is a heterogeneous disease that is categorized into four Consensus Molecular Subtypes (CMS) according to gene expression. Patients with loco-regional CC (stages II/III) lack prognostic factors, making it essential to analyze new molecular markers that can deline...

Full description

Bibliographic Details
Main Authors: Irene Fernandez-De-Los-Reyes, Marisa Gomez-Dorronsoro, Iñaki Monreal-Santesteban, Agustín Fernandez-Fernandez, Mario Fraga, Pablo Azcue, Laura Alonso, Beatriz Fernandez-Marlasca, Javier Suarez, Alicia Cordoba-Iturriagagoitia, David Guerrero-Setas
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Clinical Epigenetics
Subjects:
CMS
Colon cancer
DNA methylation
Prognostic biomarker
Online Access:https://doi.org/10.1186/s13148-023-01605-7

Internet

https://doi.org/10.1186/s13148-023-01605-7

Similar Items